Corrigendum: Targeting JUN, CEBPB and HDAC3: a novel strategy to overcome drug resistance in hypoxic glioblastoma
Yixing Gao, Bao Liu, Lan Feng, Binda Sun, Shu He, Yidong Yang, Gang Wu, Guoji E, Chang Liu, Yuqi Gao, Erlong Zhang, Bo Zhu
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHistone Deacetylase Inhibitors Research · Cancer, Hypoxia, and Metabolism · Glioma Diagnosis and Treatment
In the published article, two Supplementary Figures were missing. We provide both the splicing data and the raw images of Figure 6B in Supplementary Figure 3. The Supplementary Figure 3 and caption have been added to the original article. Moreover, we have repeated the experiments of Figure 6B and provided the figure without splicing in Supplementary Figure 4. The Supplementary Figure 4 and caption have been added to the original article.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.